Tobacco Smoking and the Risk of Atrial Fibrillation: A Systematic Review and Meta-analysis of Prospective Studies
Overview
Affiliations
Background Epidemiological studies on smoking and atrial fibrillation have been inconsistent, with some studies showing a positive association while others have found no association. It is also unclear whether there is a dose-response relationship between the number of cigarettes smoked or pack-years and the risk of atrial fibrillation. We conducted a systematic review and meta-analysis to clarify the association. Design Systematic review and meta-analysis. Methods We searched the PubMed and Embase databases for studies of smoking and atrial fibrillation up to 20 July 2017. Prospective studies and nested case-control studies within cohort studies reporting adjusted relative risk estimates and 95% confidence intervals (CIs) of atrial fibrillation associated with smoking were included. Summary relative risks (95% CIs) were estimated using a random effects model. Results Twenty nine prospective studies (22 publications) were included. The summary relative risk was 1.32 (95% CI 1.12-1.56, I= 84%, n = 11 studies) for current smokers, 1.09 (95% CI 1.00-1.18, I= 33%, n = 9) for former smokers and 1.21 (95% CI 1.12-1.31, I= 80%, n = 14) for ever smokers compared to never smokers. Comparing current versus non-current smokers the summary relative risk was 1.33 (95% CI 1.14-1.56, I= 78%, n = 10). The summary relative risk was 1.14 (95% CI 1.10-1.20, I= 0%, n = 3) per 10 cigarettes per day and 1.16 (95% CI 1.09-1.25, I= 49%, n = 2) per 10 pack-years and there was no evidence of a non-linear association for cigarettes per day, P = 0.17. Conclusions The current meta-analysis suggests that smoking is associated with an increased risk of atrial fibrillation in a dose-dependent matter, but the association is weaker among former smokers compared to current smokers.
Antithrombotic therapy in atrial flutter: To anticoagulate or not, that is the question.
Wesolek F, Szyszka P, Cichon M, Mizia-Stec K, Wybraniec M Heart Rhythm O2. 2025; 6(1):86-96.
PMID: 40060166 PMC: 11885911. DOI: 10.1016/j.hroo.2024.11.003.
Koniari I, Bozika M, Nastouli K, Tzegka D, Apostolos A, Velissaris D Biomedicines. 2025; 13(2).
PMID: 40002818 PMC: 11852994. DOI: 10.3390/biomedicines13020405.
Smoking, Alcohol Consumption, and Atrial Fibrillation: Mendelian Randomization Study.
Ye X, Wu Q, Lv Q, Hou X, Yang Y, Yang C Cardiovasc Toxicol. 2025; 25(3):341-353.
PMID: 39987412 PMC: 11885352. DOI: 10.1007/s12012-025-09964-8.
Long W, He Q, Chen S, Luo X, Yang W, Zheng J Echocardiography. 2025; 42(2):e70096.
PMID: 39980442 PMC: 11843406. DOI: 10.1111/echo.70096.
Integrated Management of Persistent Atrial Fibrillation.
Yue X, Zhou L, Zhao C Biomedicines. 2025; 13(1).
PMID: 39857675 PMC: 11760448. DOI: 10.3390/biomedicines13010091.